Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARV1 fatty acid homeostasis modulator (ARV1) is a conserved transmembrane protein containing a zinc ribbon motif at the N-terminus. It is believed to act as a lipid transporter or scramblase within the endoplasmic reticulum, regulating cholesterol and fatty acid homeostasis, as well as the asymmetry and trafficking of membrane lipids. ARV1 plays roles in glycosyl-phosphatidylinositol anchor biosynthesis, cellular stress response (especially unfolded protein response), and is essential for proper metabolic function. Loss-of-function mutations in ARV1 are associated with severe neurodevelopmental disorders such as early infantile epileptic encephalopathy (DEE38/EIEE38), and studies in animal models indicate influence over obesity, insulin sensitivity, and cholesterol metabolism. No drugs are known to directly target ARV1, but its role in fundamental lipid metabolism and neurological health positions it as a potential target for future investigation.
Not applicable; no direct pharmacological modulators yet identified
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ARV1 fatty acid homeostasis modulator (ARV1).